The FDA Calls Kyowa Hakko Kirin's Lymphoma Drug a Breakthrough Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR… Source: BioSpace You Might Also Like Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials March 4, 2018 Rubius Therapeutics Raises $100 Million in Crossover Financing February 28, 2018 NW Bio Closes 3-Year Convertible Debt Exchange And Financing, And Completes Payoff Of Last $5 Million Of 2014 Bonds June 21, 2017
NW Bio Closes 3-Year Convertible Debt Exchange And Financing, And Completes Payoff Of Last $5 Million Of 2014 Bonds June 21, 2017
